Communiqués Eli Lilly and Company Borsa Italiana

Actions

4LLY

US5324571083

Temps réel estimé Tradegate Autres places de cotation 18:13:39 17/07/2024			Varia. 5j.	Varia. 1 janv.
838 ^EUR	-4,11 %		+2,14 %	+66,00 %

17:55	Les semi-conducteurs pèsent sur les Bourses européennes, Teleperformance victime de l'IA	AO
15:14	Wall Street s'apprête à chuter en raison de la chute des valeurs technologiques et des puces à grande capitalisation.	RE

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Neuroendocrine Tumors Pipeline 2024 \| Amgen, Eli Lilly and Company, GlaxoSmithKline, Hutchison Medipharma Limited, Ipsen, Seneca Therapeutics, Crinetics Pharmaceuticals, ADC Therapeutics, BeiGene	12/07	AQ
Eli Lilly Finalizes Acquisition Agreement to Acquire Morphic for $3.2 Billion - InsideArbitrage	10/07	AQ
Weight loss drug Zepbound outperforms Ozempic in new published study	09/07	AQ
Lilly agrees $3.2b IBD acquisition	08/07	AQ
Tesla, Archer Aviation rise; Eli Lilly falls, Tuesday, 7/2/2024	02/07	AQ
TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases	27/06	AQ
Augustine Therapeutics announces EUR17 million Series A1 financing round	27/06	AQ
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria	25/06	PR
Lilly Declares Third-Quarter 2024 Dividend	24/06	PR
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs	20/06	AQ
Eli Lilly and : Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products	20/06	PU
Eli Lilly and : An Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro® and Zepbound®	20/06	PU
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks	08/06	PR
Lilly announces departure of Anat Ashkenazi, chief financial officer	05/06	PR
Eli Lilly and Company - Melissa Seymour to join Lilly as executive vice president of Global Quality	05/06	AQ
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	04/06	AQ
Eli Lilly and : Asco Lilly Oncology Presentation	03/06	PU
AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER	31/05	AQ
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases	29/05	PR
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	29/05	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

David Ricks, PDG d'Eli Lilly : Un marche de plus d'un milliard de personnes

Le 12 mars 2024 à 19:47